Evaluating the Role of Stereotactic Body Radiation Therapy With Respect to Androgen Receptor Signaling Inhibitors for Oligometastatic Prostate Cancer

PURPOSE: Outcomes of stereotactic body radiation therapy (SBRT) with respect to androgen receptor signaling inhibitors (ARSI) have not been characterized for oligometastatic prostate cancer. We sought to characterize prostate specific antigen (PSA) response and progression-free survival (PFS) after...

Descripción completa

Detalles Bibliográficos
Autores principales: Brennan, Victoria, Spektor, Alexander, Sweeney, Christopher, Choudhury, Atish, Rathkopf, Dana, Pomerantz, Mark, Hertan, Lauren, Nguyen, Paul, Martin, Neil, Balboni, Tracy, Huynh, Mai Anh, King, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767251/
https://www.ncbi.nlm.nih.gov/pubmed/35071831
http://dx.doi.org/10.1016/j.adro.2021.100808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767251/
https://www.ncbi.nlm.nih.gov/pubmed/35071831
http://dx.doi.org/10.1016/j.adro.2021.100808

Ejemplares similares